Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes
Clinical trial NCT01923181 · COMPLETED
Trial details
- NCT number
- NCT01923181
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-02
- Primary completion
- 2014-12-11
- Enrollment
- 632
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.